Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Everolimus in Thymoma and Thymic Carcinoma
NCT02049047Phase 2Completed
- Sponsor
- Armando Santoro
- Start
- Feb 2011
- Primary completion
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of everolimus in thymoma, thymic carcinoma (TC), sponsored by Armando Santoro. Started Feb 2011; status: completed.
02
Drugs
everolimus
03
Conditions
thymomathymic carcinoma (TC)
Beyond the preview
Go deeper on NCT02049047.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02049047.